Athena Athena

X

Find Radio Compass News for Apalutamide

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

https://www.globenewswire.com/news-release/2024/01/30/2820140/0/en/Kairos-Pharma-Doses-First-Patient-in-Phase-2-Trial-of-Lead-Drug-Candidate-ENV105-with-Apalutamide-to-Improve-Therapy-Sensitivity-for-Castrate-Resistant-Prostate-Cancer.html

GLOBENEWSWIRE
30 Jan 2024

https://www.newswire.ca/news-releases/erleada-r-apalutamide-240-mg-approved-as-the-only-androgen-receptor-inhibitor-with-a-once-daily-single-tablet-option-in-canada-824240082.html

NEWSWIRE
10 Aug 2023

https://www.prnewswire.com/news-releases/erleada-apalutamide-first-and-only-next-generation-androgen-receptor-inhibitor-with-once-daily-single-tablet-option-now-available-in-the-us-301787489.html

PR NEWSWIRE
03 Apr 2023

https://nation.africa/kenya/news/fda-approves-injectable-drug-for-resistant-hiv-4073822

Amina Wako NATION
03 Jan 2023

https://endpts.com/jj-takes-aurobindo-to-court-over-potential-erleada-generic/

N. DeFeudis ENDPTS
01 Jun 2022

https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-apalutamide-tablets-1649311994.pdf

FDA
06 Apr 2022

https://johnsonandjohnson.gcs-web.com/static-files/28d869b1-8230-473a-a011-e40c8bbcac15

PRESS RELEASE
14 Feb 2022

https://www.pharmaceutical-technology.com/news/jj-split-consumer-health-pharmaceutical/

PHARMACEUTICAL-TECHNOLOGY
15 Nov 2021

https://www.pharmatimes.com/news/nice_changes_its_mind_on_janssens_erleada_1376372

Lucy Parsons PHARMA TIMES
08 Sep 2021

https://www.raps.org/news-and-articles/news-articles/2021/8/fda-finalizes-guidance-on-metastasis-free-survival

Michael Mezher  RAPS
06 Aug 2021

http://www.pharmatimes.com/news/janssens_erleada_maintains_quality_of_life_for_prostate_cancer_patients_1370808

Lucy Parsons PHARMATIMES
27 May 2021

http://www.pharmafile.com/news/578303/nice-rejects-janssens-prostate-cancer-drug-erleada

PHARMAFILE
21 May 2021

https://www.businesswire.com/news/home/20210209005604/en/Janssen-Presents-Results-from-Phase-3-ACIS-Study-in-Patients-with-Metastatic-Castration-Resistant-Prostate-Cancer-Treated-with-Apalutamide%E2%96%BC-and-Abiraterone-Acetate-Combination

BUSINESSWIRE
09 Feb 2021

https://en.prnasia.com/releases/global/kangpu-to-present-two-posters-at-the-2020-american-association-for-cancer-research-aacr-annual-meeting-282967.shtml

PRNASIA
17 Jun 2020

https://www.prnewswire.com/news-releases/janssen-highlights-innovative-oncology-portfolio-and-pipeline-of-oral-biologic-and-cell-therapies-through-asco20-virtual-scientific-program-301067691.html

PRNEWSWIRE
29 May 2020

https://www.fiercepharma.com/pharma/asco-j-j-s-erleada-extends-lives-by-14-months-nonmetastatic-prostate-cancer

Carly Helfand FIERCE PHARMA
13 May 2020

https://www.prnewswire.com/news-releases/erleada-apalutamide-significantly-improved-overall-survival-in-patients-with-non-metastatic-castration-resistant-prostate-cancer-301058911.html

PRNEWSWIRE
13 May 2020

https://www.biospectrumasia.com/news/30/15422/who-to-accelerate-research-and-innovation-for-new-coronavirus.html

BIOSPECTRUMASIA
12 Feb 2020

https://www.fiercepharma.com/marketing/bayer-s-nubeqa-gets-better-chance-at-challenging-pfizer-and-j-j-prostate-cancer-key

Angus Liu FIERCE PHARMA
31 Jan 2020

http://www.pharmafile.com/news/539813/janssens-erleada-expanded-europe-cover-metastatic-hormone-sensitive-prostate-cancer

PHARMAFILE
29 Jan 2020

https://www.businesswire.com/news/home/20200129005336/en/Janssen-Announces-European-Commission-Approval-Expanded-Erleada%C2%AE%E2%96%BC/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

BUSINESSWIRE
29 Jan 2020

https://www.fiercepharma.com/pharma/esmo-j-j-s-erleada-misses-survival-mark-but-execs-see-reason-to-cheer

Carly Helfand FIERCE PHARMA
28 Sep 2019

http://pharmabiz.com/NewsDetails.aspx?aid=118419&sid=2

PHARMABIZ
27 Sep 2019

http://www.pharmabiz.com/NewsDetails.aspx?aid=118238&sid=2

PHARMABIZ
20 Sep 2019

https://www.biopharmadive.com/news/johnson-erleada-approval-prostate-cancer-pfizer-xtandi/563198/

Jacob Bell BIOPHARMADIVE
19 Sep 2019

https://www.raps.org/news-and-articles/news-articles/2019/9/fda-collaborates-with-health-canada-australia-to

Z. Brennan RAPS
18 Sep 2019

https://www.fiercepharma.com/pharma/asco-pfizer-astellas-xtandi-racks-up-more-data-for-new-prostate-cancer-use

Carly Helfand FIERCE PHARMA
03 Jun 2019

https://www.fiercepharma.com/pharma/asco-j-j-pads-case-for-new-erleada-use-prostate-cancer-survival-data

Carly Helfand FIERCE PHARMA
31 May 2019

https://www.fiercepharma.com/pharma/asco-2019-what-to-watch-for-including-keytruda-lynparza-seagen-and-more

Carly Helfand FIERCE PHARMA
31 May 2019

https://www.fiercepharma.com/marketing/j-j-eyes-prostate-cancer-boost-as-fda-accepts-erleada-for-real-time-review

Carly Helfand FIERCE PHARMA
03 May 2019

https://endpts.com/fda-tags-bayers-prostate-cancer-drug-for-priority-review-as-drugmaker-gears-up-against-rivals/

Amber Tong ENDPTS
30 Apr 2019

https://www.prnewswire.com/news-releases/janssen-submits-application-to-us-fda-seeking-approval-of-erleada-apalutamide-for-patients-with-metastatic-castration-sensitive-prostate-cancer-300840126.html

PR NEWSWIRE
29 Apr 2019

https://www.ema.europa.eu/documents/product-information/erleada-epar-product-information_en.pdf

EMA
22 Mar 2019

http://www.evaluate.com/vantage/articles/news/trial-results/asco-gu-bayer-and-orion-have-their-work-cut-out-darolutamide?mkt_tok=eyJpIjoiT0RKa04yTTVaV1ZoWWpZeCIsInQiOiJ4bnU5VmdUSnBIbWhEdUQ1ZDd4TmQxNTNpY1lLY0taSndKSUpWU0wzNE9memF2TktEM2tSeEhnVVR0dXRIdko1ZGxTQ1hJRHh1YXNCNzA1eHpWUXpuVzZYZWRNVk1CdThEVmh5dGJheU1TZEpxeWhqNnlUb25DaDVkMWM5Y0hXdSJ9

Jacob Plieth EVALUATE PHARMA
16 Feb 2019

https://www.biopharmadive.com/news/new-prostate-cancer-data-puts-bayer-drug-in-line-with-pfizer-jj-rivals/548570/

Andrew Dunn BIOPHARMA DIVE
15 Feb 2019

https://www.reuters.com/article/us-bayer-orion-prostate-cancer/bayer-stresses-drugs-tolerability-in-bid-for-prostate-cancer-market-idUSKCN1Q32YV

Ludwig Burger REUTERS
15 Feb 2019

https://www.fiercepharma.com/pharma/j-j-s-erleada-trial-stops-early-good-news-setting-up-case-for-new-prostate-cancer-nod

Carly Helfand FIERCE PHARMA
31 Jan 2019

https://www.pharmaceutical-technology.com/news/us-idmc-recommends-janssen-erleada-mcspc/

Allie Nawrat PHARMA-TECH
31 Jan 2019

https://endpts.com/jj-scores-another-phiii-win-for-erleada-as-it-continues-to-build-a-blockbuster-franchise/

John Carroll ENDPTS
31 Jan 2019

https://www.fiercepharma.com/marketing/pfizer-s-xtandi-blows-by-erleada-hot-start-new-prostate-cancer-field

Carly Helfand FIERCE PHARMA
30 Jan 2019

http://www.pharmatimes.com/news/eu_licence_granted_for_erleada_in_prostate_cancer_1275526

Anna Smith PHARMA TIMES
18 Jan 2019

https://endpts.com/jj-fronts-new-cancer-drug-pact-with-500m-in-cash-for-argenxs-aml-antibody/

John Carroll ENDPTS
03 Dec 2018

http://www.pharmabiz.com/NewsDetails.aspx?aid=112362&sid=2

PHARMABIZ
20 Nov 2018

https://www.businesswire.com/news/home/20181116005228/en/Janssen-receives-positive-CHMP-opinion-ERLEADA%E2%84%A2-apalutamide

BUSINESSWIRE
16 Nov 2018

https://www.raps.org/news-and-articles/news-articles/2018/11/fda-drafts-guidance-on-using-metastasis-free-survi?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2013%20November

Ana Mulero RAPS
13 Nov 2018

https://www.pharmacompass.com/pdf/news/anvisa-approved-janssen-cilag-farmacêuticas-erleada-for-prostate-cancer-1540288421.pdf

ANVISA
20 Oct 2018

https://www.fiercepharma.com/marketing/pfizer-and-astellas-xtandi-ready-to-vie-j-j-nonmetastatic-prostate-cancer

Tracy Staton FIERCE PHARMA
17 Jul 2018

https://www.raps.org/news-and-articles/news-articles/2018/7/erleada-gains-first-approval-under-new-tga-work-sh?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%205%20July%202018%20%28copy%29

Ana Mulero RAPS
06 Jul 2018
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY